JPRN-UMIN000006502已完成未知
The effect of combination therapy of fluticasone furoate nasal spray with levocetirizine hydrochloride in patients with Japanese cedar pollinosis in an artificial exposure chamber(OHIO Chamber). - The effect of combination therapy of fluticasone furoate nasal spray with levocetirizine hydrochloride in patients with Japanese cedar pollinosis.
ippon Medical School0 个研究点目标入组 42 人开始时间: 2011年10月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) A hisotry of nasal and/or ocular disease 2) Evidence of upper and/or lower respiratory tract inflammation within 2 weeks prior to IC 3) An episode of sinusitis within 30 days prior to IC 4) A hisotry of treatment with steroid injection within 6 months prior to IC 5) A hisotry of treatment with steroid (oral and topical) within 4 weeks prior to IC 6) A history of asthma (include of child asthma) 7) A history of anaphylaxis 8) Patients who have the hypersensitivity to study drugs 9) Patients with desensitization therapy 10) Patients with nasal anatomical deformities leading to obstruction within 1 year prior to IC 11) Patients with cardiac, renal disease, or hepatic insufficiency 12) Pregnancy, breast-feeding woman, potencial pregnancy, patient who wish to become pregnant during this study 13) Patients who were judged to be unsuitable for patient enrollment by the doctor
研究者
相似试验
已完成
不适用
Additional effects of moderate-dose fluticasone and salmeterol combination therapy on exacerbations and airflow limitations in patients with COPD in JapaCOPDJPRN-UMIN000007544Kyusyu Asthma & COPD Forum1,008
已完成
不适用
Additional effects of moderate-dose fluticasone and salmeterol combination therapy on exacerbations and airflow limitations in patients with COPD in JapaCOPDJPRN-UMIN000003403Kyusyu Asthma & COPD Forum1,008
进行中（未招募）
1 期
Efficacy of Fluticasone Propionate associated With Salmeterol underwent allogeneic hematopoietic stem cell transplantatioBronchiolitis Obliterative Syndrome after hematopoietic stem cell transplantation (HSCT)..EUCTR2020-003010-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)243
进行中（未招募）
1 期
Single Inhaler Triple Therapy (fluticasone furoate + vilanterol trifenatate + umeclidinium bromide) (inhaled) - COPDEUCTR2017-004369-29-ESGlaxoSmithKline, S.A.3,000
进行中（未招募）
1 期
Single Inhaler Triple Therapy (fluticasone furoate + vilanterol trifenatate + umeclidinium bromide) (inhaled) - COPDChronic Obstructive Pulmonary Disease (COPD) which may be called emphysema or chronic bronchitis.MedDRA version: 21.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 100000004855EUCTR2017-004369-29-NLGlaxoSmithKline Research & Development Limited3,341